Background: Hypertension is the most common reason for postpartum hospital readmission. Better prediction of postpartum readmission will improve the health care of patients. These models will allow better use of resources and decrease health care costs.
Objective: This study aimed to evaluate clinical predictors of postpartum readmission for hypertension using a novel machine learning (ML) model that can effectively predict readmissions and balance treatment costs. We examined whether blood pressure and other measures during labor, not just postpartum measures, would be important predictors of readmission.
Methods: We conducted a retrospective cohort study from the PeriData website data set from a single midwestern academic center of all women who delivered from 2009 to 2018. This study consists of 2 data sets; 1 spanning the years 2009-2015 and the other spanning the years 2016-2018. A total of 47 clinical and demographic variables were collected including blood pressure measurements during labor and post partum, laboratory values, and medication administration. Hospital readmissions were verified by patient chart review. In total, 32,645 were considered in the study. For our analysis, we trained several cost-sensitive ML models to predict the primary outcome of hypertension-related postpartum readmission within 42 days post partum. Models were evaluated using cross-validation and on independent data sets (models trained on data from 2009 to 2015 were validated on the data from 2016 to 2018). To assess clinical viability, a cost analysis of the models was performed to see how their recommendations could affect treatment costs.
Results: Of the 32,645 patients included in the study, 170 were readmitted due to a hypertension-related diagnosis. A cost-sensitive random forest method was found to be the most effective with a balanced accuracy of 76.61% for predicting readmission. Using a feature importance and area under the curve analysis, the most important variables for predicting readmission were blood pressures in labor and 24-48 hours post partum increasing the area under the curve of the model from 0.69 (SD 0.06) to 0.81 (SD 0.06), (P=.05). Cost analysis showed that the resulting model could have reduced associated readmission costs by US $6000 against comparable models with similar F-score and balanced accuracy. The most effective model was then implemented as a risk calculator that is publicly available. The code for this calculator and the model is also publicly available at a GitHub repository.
Conclusions: Blood pressure measurements during labor through 48 hours post partum can be combined with other variables to predict women at risk for postpartum readmission. Using ML techniques in conjunction with these data have the potential to improve health outcomes and reduce associated costs. The use of the calculator can greatly assist clinicians in providing care to patients and improve medical decision-making.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11437324 | PMC |
http://dx.doi.org/10.2196/48588 | DOI Listing |
BMC Pregnancy Childbirth
December 2024
Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel.
Background: We aim to identify risk factors contributing to extended rehospitalizations in patients diagnosed with postpartum endometritis requiring intravenous antibiotics.
Methods: This retrospective cohort study examined postpartum endometritis patients readmitted for treatment from 2014 to 2022, comparing short (≤ 48 h) and prolonged hospitalization (> 48 h). Data included patient demographics, medical history, presentation parameters, vaginal examination findings, sonographic data, laboratory results, and details of the current labor to create a scoring system predicting prolonged hospitalization risk.
Obesity (Silver Spring)
January 2025
Department of Obstetrics & Gynecology, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Objective: The objective of this study was to examine whether obesity without preexisting or gestational comorbidities is associated with postpartum hospital use (PHU).
Methods: We studied 2016 to 2018 birth certificate and discharge data on 178,729 New York City births without International Classification of Diseases, Tenth Revision (ICD-10) codes at delivery for diabetes; hypertension; placental disease; anemia; thyrotoxicosis; bariatric surgery; and pulmonary, cardiac, renal, bleeding, autoimmune, digestive, neuromuscular, mental, or substance-use disorders. We defined PHU as ≥1 readmission or emergency department visit within 30 days of delivery discharge.
Pregnancy Hypertens
December 2024
Section of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Chicago Medicine, IL, United States. Electronic address:
Objective: To describe postpartum visit attendance and postpartum blood pressure control among patients enrolled in a remote patient monitoring program and compare these outcomes by race.
Study Design: A prospective cohort study of postpartum patients with a diagnosis of hypertensive disorders of pregnancy at the University of Chicago between October 2021 and April 2022. All patients received remote patient monitoring as routine care but consented separately for the use of their data.
Am J Obstet Gynecol MFM
December 2024
Department of Obstetrics and Gynecology, University of California-San Francisco, San Francisco, CA.
Background: Given risks associated with CHD in the postpartum period, epidemiologic data identifying risk factors and timing of complications may be useful in improving postpartum care.
Objective: The objectives of this study were to determine timing of, risk factors for, and complications associated with 60-day postpartum readmissions following deliveries with maternal congenital heart disease (CHD).
Study Design: The 2010-2020 Nationwide Readmissions Database was used for this retrospective cohort study.
Am J Obstet Gynecol MFM
December 2024
Prisma Health Upstate/University of South Carolina School of Medicine Greenville, Greenville, SC.
Background: Postpartum hypertension is an increasingly prevalent problem and optimizing its treatment is imperative in reducing maternal morbidity and improving long-term health outcomes. Despite this, data on treatment of postpartum hypertension is limited. While most available studies focus on labetalol and nifedipine ER, these medications are not frequently used for hypertension treatment in the non-obstetric setting.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!